Lipidomics studies on macrophages - bone marrow-derived macrophages treated with 25-hydroxy-cholesterol +/- lipid-depleted media containing compactin
Introduction | Browse | DownloadMouse-over the above links for more information
Treatment details
| LM ID | Analyte | Treatment | Time(hrs) | Sample ID | Value | Units |
|---|---|---|---|---|---|---|
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 0.0 | BCD100427B002 | 25.9 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 0.5 | BCD100427B005 | 38.1 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 1.0 | BCD100427B009 | 17 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 2.0 | BCD100427B013 | 6.59 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 4.0 | BCD100427B017 | 6.74 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 8.0 | BCD100427B021 | 31.4 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 12.0 | BCD100427B025 | 8.41 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | Lipid-depleted/compactin | 24.0 | BCD100427B029 | 25.5 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 0.0 | BCD100427B001 | 7.52 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 0.5 | BCD100427B003 | 6.21 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 1.0 | BCD100427B007 | 7.54 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 2.0 | BCD100427B011 | 8.66 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 4.0 | BCD100427B015 | 8.93 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 8.0 | BCD100427B019 | 46 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 12.0 | BCD100427B023 | 21.2 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | C | 24.0 | BCD100427B027 | 35.2 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 0.5 | BCD100427B006 | 15.7 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 1.0 | BCD100427B010 | 22.7 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 2.0 | BCD100427B014 | 6.38 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 4.0 | BCD100427B018 | 10 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 8.0 | BCD100427B022 | 12.9 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 12.0 | BCD100427B026 | 26.6 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol + Lipid-depleted/compactin | 24.0 | BCD100427B030 | 21.2 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 0.5 | BCD100427B004 | 2.04 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 1.0 | BCD100427B008 | 16.2 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 2.0 | BCD100427B012 | 10.4 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 4.0 | BCD100427B016 | 8.98 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 8.0 | BCD100427B020 | 18.6 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 12.0 | BCD100427B024 | 13.5 | pmol/sample |
| LMFA01010015 | Pentadecanoic acid | 25OH-Chol | 24.0 | BCD100427B028 | 7.3 | pmol/sample |